VJOncology is committed to improving our service to you

ASCO 2019 | Results of Phase III study into treatment for NSCLC

VJOncology is committed to improving our service to you

Vanita Noronha

Vanita Noronha, MBBS, MD, DM, of the Tata Memorial Center, Mumbai, India, discusses the results of a Phase III study investigating gefitinib versus combination therapy in the treatment of non-small cell lung cancer (NSCLC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter